tiprankstipranks

James Czirr Insider Profile

4 Followers
James Czirr, Director at Galectin Therapeutics, holds 2.65M shares in Galectin Therapeutics (Ticker: GALT).
tipranks
James Czirr

James Czirr
Galectin Therapeutics (GALT)
Director

Ranked #61,973 out of 78,624 Corporate Insiders

Profitable Transactions

50%
7 out of 14 Profitable Transactions

Average Return

-10.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
100.00%
A breakdown of James Czirr's holdings

Insider Roles

Galectin Therapeutics
(GALT)
Director
Roles that James Czirr holds in companies

Most Profitable Insider Trade

Stock:
Galectin Therapeutics
(GALT)
Rating:Informative Buy
Date:May 18, 2012 - May 18, 2013
Return:+115.60%
The most profitable trade made by James Czirr

James Czirr's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Galectin Therapeutics
Jun 20, 2018
Director
Uninformative Sell
1.31M
$7.02M
Success Rate for
GALT
7 out of 14 profitable transactions on
GALT
50%
Average Return for
GALT
Average return per transaction on
GALT
-10.82%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Apr 15, 2011
Uninformative Buy
$5.97K
-
$1.08
Feb 02, 2010
Uninformative Buy
$72.81K
-
$0.28
Apr 28, 2010
Uninformative Buy
$2.64K
-
$0.44
Aug 24, 2009
Uninformative Buy
$103.83K
-
$0.50
Aug 17, 2009
Uninformative Buy
$1.32K
-
$0.22
List of latest transactions for each holding click on a transaction to see James Czirr's performance on stock

James Czirr insider profile FAQ

What is the percentage of profitable transactions made by James Czirr?
The percentage of profitable transactions made by James Czirr is 50%.
    What is the average return per transaction made by James Czirr?
    The average return per transaction made by James Czirr is -10.80%.
      What stocks does James Czirr hold?
      James Czirr holds: GALT stocks.
        What was James Czirr’s latest transaction?
        James Czirr latest transaction was an Uninformative Sell of $1.31M.
          What was James Czirr's most profitable transaction?
          James Czirr’s most profitable transaction was an Informative Buy of GALT stock on May 18, 2012. The return on the trade was 115.60%.
            What is James Czirr's role in Galectin Therapeutics?
            James Czirr's role in Galectin Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.